ADAR1 Capital Management, LLC — Insider Trades & Holdings | InsiderBid

ADAR1 Capital Management, LLC

Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: -$74.6M

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
INM	InMed Pharmaceuticals Inc.	$841.2K	$0	+$841.2K	892,101	Sep 16
TENX	Tenax Therapeutics, INC.	$4.8M	$0	+$4.8M	6.5M	Sep 3
NXTC	NextCure, Inc.	$1.7M	$0	+$1.7M	722,419	Jul 31
RLYB	Rallybio Corp	$4.2M	$0	+$4.2M	926,352	May 19
KROS	Keros Therapeutics, Inc.	$9.5M	$95.7M	-$86.2M	0	Oct 15, 2025

InMed Pharmaceuticals Inc.

+$841.2K

Bought

$841.2K

Sold

$0

Held

892,101

Tenax Therapeutics, INC.

+$4.8M

Bought

$4.8M

Sold

$0

Held

6.5M

NextCure, Inc.

+$1.7M

Bought

$1.7M

Sold

$0

Held

722,419

Rallybio Corp

+$4.2M

Bought

$4.2M

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

1 of 15 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 15 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Company	Past deadline	Largest line	Source
May 16, 2025	Jun 11, 2025	KROSKeros Therapeutics, Inc.	15days	—	Filing ↗

Keros Therapeutics, Inc.

15days

Traded May 16, 2025 · filed Jun 11, 2025Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.

Trade history

The 61 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Sep 16	INM	InMed Pharmaceuticals Inc.	PBUY	8,340	$1.29	$10.8K	+0.9%	Open the original filing on SEC.gov
Sep 15	INM	InMed Pharmaceuticals Inc.	PBUY	54,256	$1.30	$70.4K	+6.5%	Open the original filing on SEC.gov

INMPBUY$10.8K

InMed Pharmaceuticals Inc.Sep 16

8,340 sh @ $1.29 · +0.9% own

INMPBUY$70.4K

InMed Pharmaceuticals Inc.Sep 15

54,256 sh @ $1.30 · +6.5% own

INMPBUY$36.9K

InMed Pharmaceuticals Inc.Sep 14

28,505 sh @ $1.29 · +3.6% own

TENXPBUY$1.6M

Tenax Therapeutics, INC.Sep 3

900,000 sh @ $1.78 · +16.0% own

TENXPBUY$337.6K

Tenax Therapeutics, INC.Sep 2

187,704 sh @ $1.80 · +3.5% own

TENXPBUY$321.6K

Tenax Therapeutics, INC.Sep 1

179,058 sh @ $1.80 · +3.4% own

TENXPBUY$722.6K

Tenax Therapeutics, INC.Aug 31

403,571 sh @ $1.79 · +8.3% own

TENXPBUY$188.4K

Tenax Therapeutics, INC.Aug 24

107,374 sh @ $1.75 · +2.3% own

TENXPBUY$1.3M

Tenax Therapeutics, INC.Aug 21

716,369 sh @ $1.77 · +17.8% own

TENXPBUY$359.5K

Tenax Therapeutics, INC.Aug 20

202,124 sh @ $1.78 · +5.3% own

NXTCPBUY$38.4K

NextCure, Inc.Jul 31

8,003 sh @ $4.80 · +1.1% own

NXTCPBUY$124.5K

NextCure, Inc.Jul 31

25,000 sh @ $4.98 · +3.6% own

NXTCPBUY$16.4K

NextCure, Inc.Jul 31

3,300 sh @ $4.98 · +0.5% own

NXTCPBUY$385.8K

NextCure, Inc.Jul 30

77,850 sh @ $4.96 · +12.8% own

NXTCPBUY$490K

NextCure, Inc.Jul 30

100,000 sh @ $4.90 · +19.7% own

NXTCPBUY$120.3K

NextCure, Inc.Jul 30

25,000 sh @ $4.81 · +5.2% own

NXTCPBUY$100K

NextCure, Inc.Jul 30

20,000 sh @ $5.00 · +4.3% own

NXTCPBUY$100K

NextCure, Inc.Jul 30

20,000 sh @ $5.00 · +4.5% own

NXTCPBUY$248.6K

NextCure, Inc.Jul 30

50,000 sh @ $4.97 · +12.7% own

NXTCPBUY$8K

NextCure, Inc.Jul 29

1,600 sh @ $5.00 · +0.4% own

NXTCPBUY$9.1K

NextCure, Inc.Jul 29

1,810 sh @ $5.00 · +0.5% own

NXTCPBUY$31.7K

NextCure, Inc.Jul 28

6,400 sh @ $4.95 · +1.7% own

NXTCPBUY$39K

NextCure, Inc.Jul 27

7,798 sh @ $5.00 · +2.1% own

INMPBUY$1.6K

InMed Pharmaceuticals Inc.Jul 15

1,000 sh @ $1.56 · +0.1% own

RLYBPBUY$2.8K

Rallybio CorpMay 19

200 sh @ $13.80 · +<0.1% own

RLYBPBUY$139.8K

Rallybio CorpMay 19

10,000 sh @ $13.98 · +1.1% own

INMPBUY$299.8K

InMed Pharmaceuticals Inc.May 19

200,000 sh @ $1.50 · +33.3% own

INMPBUY$312.1K

InMed Pharmaceuticals Inc.May 19

200,000 sh @ $1.56 · +50.0% own

INMPBUY$109.7K

InMed Pharmaceuticals Inc.May 19

68,551 sh @ $1.60 · +20.7% own

RLYBPBUY$84K

Rallybio CorpMay 18

6,009 sh @ $13.98 · +0.7% own

RLYBPBUY$2.8K

Rallybio CorpMay 15

200 sh @ $13.95 · +<0.1% own

RLYBPBUY$1.4K

Rallybio CorpMay 15

100 sh @ $13.80 · +<0.1% own

RLYBPBUY$1.1M

Rallybio CorpMay 13

75,178 sh @ $14.00 · +9.0% own

RLYBPBUY$56.3K

Rallybio CorpMay 13

4,081 sh @ $13.80 · +0.5% own

RLYBPBUY$11.1K

Rallybio CorpMay 12

800 sh @ $13.83 · +0.1% own

RLYBPBUY$278.6K

Rallybio CorpMay 11

19,900 sh @ $14.00 · +2.5% own

RLYBPBUY$350K

Rallybio CorpMay 11

25,000 sh @ $14.00 · +3.2% own

RLYBPBUY$71.4K

Rallybio CorpMay 11

5,100 sh @ $14.00 · +0.7% own

RLYBPBUY$491.3K

Rallybio CorpMay 5

35,101 sh @ $14.00 · +4.7% own

RLYBPBUY$1.6M

Rallybio CorpMay 4

116,904 sh @ $13.97 · +18.6% own

RLYBPBUY$54.2K

Rallybio CorpMay 4

3,900 sh @ $13.90 · +0.6% own

KROSSSELL$13.2M

Keros Therapeutics, Inc.Oct 15, 2025

743,358 sh @ $17.75 · -100.0% own

KROSSSELL$4.5M

Keros Therapeutics, Inc.Oct 15, 2025

254,669 sh @ $17.75 · -100.0% own

KROSSSELL$77.9M

Keros Therapeutics, Inc.Oct 15, 2025

4.4M sh @ $17.75 · -100.0% own

KROSXXITM◆—

Keros Therapeutics, Inc.Jun 20, 2025

2 sh

KROSXXITM◆—

Keros Therapeutics, Inc.Jun 20, 2025

14 sh

KROSXXITM◆—

Keros Therapeutics, Inc.Jun 20, 2025

1 sh

KROSXXITM$14K

Keros Therapeutics, Inc.Jun 20, 2025

200 sh @ $70.00 · <0.1% own

KROSXXITM$98K

Keros Therapeutics, Inc.Jun 20, 2025

1,400 sh @ $70.00 · <0.1% own

KROSXXITM$6K

Keros Therapeutics, Inc.Jun 20, 2025

100 sh @ $60.00 · 0.0% own

KROSEEXPS◆—

Keros Therapeutics, Inc.May 16, 2025

178 sh

KROSEEXPS◆—

Keros Therapeutics, Inc.May 16, 2025

836 sh

KROSEEXPS◆—

Keros Therapeutics, Inc.May 16, 2025

300 sh

KROSJOTHER◆—

Keros Therapeutics, Inc.Apr 9, 2025

74,333 sh

KROSJOTHER◆—

Keros Therapeutics, Inc.Apr 9, 2025

500,000 sh

KROSJOTHER◆—

Keros Therapeutics, Inc.Apr 9, 2025

325,000 sh

KROSPBUY$767.9K

Keros Therapeutics, Inc.Apr 9, 2025

74,333 sh @ $10.33 · +1.7% own

KROSPBUY$5.2M

Keros Therapeutics, Inc.Apr 9, 2025

500,000 sh @ $10.33 · +13.1% own

KROSPBUY$3.2M

Keros Therapeutics, Inc.Apr 9, 2025

325,000 sh @ $9.86 · +9.3% own

KROSPBUY$153.8K

Keros Therapeutics, Inc.Apr 9, 2025

16,365 sh @ $9.40 · +2.3% own

KROSPBUY$174.4K

Keros Therapeutics, Inc.Apr 9, 2025

18,560 sh @ $9.40 · +0.5% own